Adma Biologics (ADMA) CEO Grossman sells $338k in shares
NeutralFinancial Markets

ADMA Biologics CEO, Adam Grossman, has sold $338,000 worth of shares in the company. This move is significant as it may indicate the CEO's confidence in the company's future or a personal financial decision. Such transactions can impact investor sentiment and market perception, making it important for stakeholders to stay informed.
— Curated by the World Pulse Now AI Editorial System